Patent No. EP3280416 (titled "Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone Esters") was filed by Janssen Pharmaceutica on Mar 30, 2016. The application was issued on Apr 22, 2020.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Get instant alerts for new documents